Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid [NA]
A completed clinical trial evaluated a shared decision-making conversation aid to improve patient selection for thyroid biopsy; results have…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations [Phase 2]
This entry reports the completion of a Phase II trial of tipifarnib in HRAS-mutant squamous cell carcinoma of the head and neck, with result…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
This clinical trial evaluated parathyroid vascularization during total thyroidectomy using indocyanine green angiography; the study status w…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Energy Metabolism in Thyroidectomized Patients [Phase 2]
Phase 2 clinical trial update on energy metabolism in thyroidectomized patients. The study has completed and posted results (June 14, 2024) …
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: The Effect of the Number of Central Lymph Nodes on Changes in Parathyroid Function
This clinical trial update reports on a completed study evaluating how the number of central lymph nodes affects parathyroid function in thy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery
A completed clinical trial evaluating whether using head-mounted magnifying glasses during thyroid cancer surgery affects postoperative para…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Nivolumab Plus Ipilimumab in Thyroid Cancer [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and ipilimumab in thyroid cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Risk of Malignancy in Endemic Long Standing Nodular Goitres: a Prospective Cohort Study
This document reports results from a prospective cohort study assessing the risk of thyroid cancer in individuals with long-standing endemic…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers [EARLY_Phase 1]
Early-phase (Phase 1) trial update evaluating radioiodine (RAI) plus immunotherapy for recurrent/metastatic thyroid cancer; results were pos…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer [Phase 1, Phase 2]
Phase I/II trial of MLN0128 in metastatic anaplastic thyroid cancer and poorly differentiated or radioiodine-refractory differentiated thyro…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer [Phase 2]
Phase 2 trial evaluating famitinib in combination with adequreblimab for advanced thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer [Phase 2]
Phase 2 study assessing regorafenib as second or third line therapy for metastatic medullary thyroid carcinoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) [Phase 2]
A Phase 2 prospective, multi-centre trial evaluating redifferentiation therapy in patients with radioiodine-refractory thyroid cancer (I-FIR…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer [Phase 3]
A Phase III clinical trial evaluating prophylactic central neck dissection in low-risk papillary thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Molecular Testing to Direct Extent of Initial Thyroid Surgery [Phase 2]
Phase 2 clinical trial evaluating molecular testing to guide the extent of initial thyroid surgery for thyroid cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition [Phase 2]
Phase 2 clinical trial investigating MAPK inhibition to enhance radioiodine uptake in radioiodine-refractory metastatic thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating intensity-modulated radiation therapy (IMRT) for non-anaplastic non-medullary thyroid cancer has completed…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial evaluating PD-1 inhibitor plus anlotinib with multimodal radiotherapy for recurrent or metastatic anaplastic thyroi…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer [Phase 3]
A Phase 3 trial evaluating whether metformin affects fertility in women treated with radioactive iodine (131I) for thyroid cancer is not yet…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer [Phase 2]
Phase 2 trial investigating total thyroidectomy with or without prophylactic central neck lymph node dissection in low-risk papillary thyroi…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients [Phase 4]
Phase 4 clinical trial update on 99mTc Sestamibi scans in thyroglobulin-positive, scan-negative differentiated thyroid cancer patients; stat…